24 HR amphetamine 12.5 MG Extended Release Oral Tablet

RxCUI: 1739803
RxNorm name: 24 HR amphetamine 12.5 MG Extended Release Oral Tablet
Display name: 24 HR amphetamine 12.5 MG Extended Release Oral Tablet
Full name: 24 HR amphetamine 12.5 MG Extended Release Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Adzenys XR-ODT	AMPHETAMINE	Neos Therapeutics Brands, LLC	c1179269-00b5-48ea-972d-31e614e99b7e	2026-05-06	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1739803
Amphetamine Extended-Release	AMPHETAMINE EXTENDED-RELEASE	Neos Therapeutics, LP	48d0f55c-f847-4d26-b2ed-94b5a2770228	2025-09-24	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1739803
Amphetamine	AMPHETAMINE	Teva Pharmaceuticals, Inc.	243e88e7-6621-47e9-8d5c-3f79bcb088bb	2025-09-01	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1739803

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
c1179269-00b5-48ea-972d-31e614e99b7e	amphetamine 12.5 MG 24HR Extended Release Distintegrating Oral Tablet [PSN] · 24 HR amphetamine 12.5 MG Extended Release Oral Tablet [SCD] · amphetamine 12.5 MG 24 HR Extended Release Distintegrating Oral Tablet [SY]	3	15	These highlights do not include all the information needed to use ADZENYS XR-ODT™ safely and effectively. See full prescribing information for ADZENYS XR-ODT. ADZENYS XR-ODT (amphetamine) extended-release orally disintegrating tablets, CII Initial U.S. Approval: 1960	20260506
48d0f55c-f847-4d26-b2ed-94b5a2770228	amphetamine 12.5 MG 24HR Extended Release Distintegrating Oral Tablet [PSN] · 24 HR amphetamine 12.5 MG Extended Release Oral Tablet [SCD] · amphetamine 12.5 MG 24 HR Extended Release Distintegrating Oral Tablet [SY]	3	5	These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS . AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS, CII Initial U.S. Approval: 1960	20250924
243e88e7-6621-47e9-8d5c-3f79bcb088bb	amphetamine 12.5 MG 24HR Extended Release Distintegrating Oral Tablet [PSN] · 24 HR amphetamine 12.5 MG Extended Release Oral Tablet [SCD] · amphetamine 12.5 MG 24 HR Extended Release Distintegrating Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS. AMPHETAMINE extended-release orally disintegrating tablets, CII Initial U.S. Approval: 1960	20250901